INOVELON

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom

Active ingredients

The drug INOVELON contains one active pharmaceutical ingredient (API):

1 Rufinamide UNII WFW942PR79 - RUFINAMIDE

Rufinamide is an anticonvulsant medication. Rufinamide modulates the activity of sodium channels, prolonging their inactive state. Read about Rufinamide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
INOVELON Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AF03	Rufinamide	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AF Carboxamide derivatives
Discover more medicines within N03AF03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 533220010002417, 533220010002517, 533220010002617, 533220010002717, 542717060004202, 542717060004302, 542717060004402, 542717060004502, 542717060004602, 542717060004702, 542718070004802, 542718070004902, 542718070005002, 542718070005102
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 5748-MEE-1220, 5750-MEE-1220
Country: EE	Ravimiamet	Identifier(s): 1280168, 1280179, 1280180, 1280191, 1280203, 1280214, 1280225, 1280236, 1280247, 1280258, 1280269, 1280270, 1280281, 1280292, 1280304, 1280315, 1549740, 1849596
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 06378001, 06378009, 06378015, 06378017
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 034939, 084860, 446618, 597767
Country: FR	Base de données publique des médicaments	Identifier(s): 62205873, 65037644, 65869160, 67454800
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 128622, 131240, 131243, 182687, 203439
Country: HK	Department of Health Drug Office	Identifier(s): 64097, 64098, 64099
Country: IE	Health Products Regulatory Authority	Identifier(s): 21546, 29701, 29730, 29785
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6669, 6670, 6671
Country: IT	Agenzia del Farmaco	Identifier(s): 038217016, 038217028, 038217030, 038217042, 038217055, 038217067, 038217079, 038217081, 038217093, 038217105, 038217117, 038217129, 038217131, 038217143, 038217156, 038217168, 038217170
Country: JP	医薬品医療機器総合機構	Identifier(s): 1139012F1023, 1139012F2020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1028578, 1028579, 1028580, 1028581, 1028582, 1028583, 1028584, 1028585, 1028586, 1028587, 1028588, 1028589, 1028590, 1028591, 1028592, 1064022
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 101222, 98825, 98833
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 20996, 20997, 20998
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100310996, 100311004, 100311010, 100311027
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W51823001, W51823002, W51823003, W51823004, W51823005, W51824001, W51824002, W51824003, W51824004, W51824005, W51825001, W51825002, W51825003, W51825004, W51825005, W51825006
Country: SG	Health Sciences Authority	Identifier(s): 15146P